Cancer News and Research

Latest Cancer News and Research

Reduced dose anthracycline post-breast cancer surgery has no effect on outcome

Canadian researchers have discovered that there is a low risk of adverse effect from reducing post-op chemo by up to 25%, according to findings published in the online journal ecancermedicalscience.

20 Jul 2008

Stem cell chicken and egg debate moves to unlikely arena: the testes

Logic says it has to be the niche. As air and water preceded life, so the niche, that hospitable environment that shelters adult stem cells in many tissues and provides factors necessary to keep them young and vital, must have emerged before its stem cell dependents.

20 Jul 2008

Alan Jones' surgery for prostate cancer a success

The veteran radio broadcaster Alan Jones has reportedly had successful surgery for prostate cancer.

20 Jul 2008

Study looks at UK's controversial choice of HPV vaccine

The UK government may save up to £18.6 million a year by deciding to use the HPV vaccine Cervarix, given that it is equally effective as the more expensive Gardasil in preventing cervical abnormalities, according to a study published on BMJ.com.

19 Jul 2008

Functional human blood vessels grown in mice using cells from adult human donors

For the first time, researchers have successfully grown functional human blood vessels in mice using cells from adult human donors - an important step in developing clinical strategies to grow tissue, researchers report in Circulation Research: Journal of the American Heart Association.

19 Jul 2008

A search for the best prostate cancer treatment

A new Cancer Research UK clinical trial has been launched to investigate the best treatment options for men who have had surgery for early stage prostate cancer.

18 Jul 2008

Breast cancer researchers call for ethnicity to be taken into account when developing treatments

Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, according to a new Comment piece in today's Lancet by researchers from Imperial College London.

17 Jul 2008

You are not alone - help for breast cancer patients

Breast cancer is the most common female cancer in the UK, affecting one in nine women at some point in their life. The first patient-led DVD for women with breast cancer who are considering breast reconstruction will be launched today. It is hoped the DVD will change the way information is provided for women facing difficult surgical choices.

17 Jul 2008

China Medicine Corporation grated Australian patent for recombinant Aflatoxin Detoxifizyme

China Medicine Corporation announced today that it obtained a patent from Australia Patent Office for recombinant Aflatoxin Detoxifizyme (rADTZ). The patent is valid through January 13, 2025.

17 Jul 2008

Fred Hutchinson awarded $7.6 million to research how genetic variations influence risk of common diseases

Researchers at Fred Hutchinson Cancer Research Center have received a $7.6 million, four-year grant from the National Human Genome Research Institute to better understand the genetic and biological roots of common diseases. The Hutchinson Center is one of four U.S. research institutes to receive grants totaling about $31 million toward this effort.

17 Jul 2008

Awareness of the role of physical activity in colon cancer prevention

Many experts now consider colon cancer a largely preventable disease, but a new study finds that primary care doctors might not always inform patients about one important step they can take to reduce their risk: becoming more physically active.

17 Jul 2008

Sale of liver disease therapeutic patents

IpAuctions, Inc. will auction the worldwide biotherapeutic patents previously owned by Cell Works Inc., a Maryland-based biotech company, and acquired by CellPoint Diagnostics, Inc., based in Mountain View, Calif. These patents primarily consist of organ-targeted drug delivery systems to combat liver disease.

17 Jul 2008

Researchers find better way to distinguish melanoma from some benign moles

University of Rochester Medical Center researchers found a new protein produced excessively in malignant melanoma, a discovery that is particularly relevant as skin cancer rates climb dramatically among young women.

17 Jul 2008

Hormesis deserves the respect and attention of toxicologists

A comprehensive review published in Environmental Toxicology and Chemistry argues that toxicologists can positively affect public health and reduce the economic costs of drug treatment by increasing their knowledge of hormesis and applying its principles to their discipline.

17 Jul 2008

EpiCept and GNI partner to develop anti-viral hepatitis drug in Asia

GNI Ltd and EpiCept Corporation have announced that they have reached agreement to develop a new therapeutic drug, EP1013, in Asia, Australia, and New Zealand, for late-stage viral infection-induced hepatitis. EpiCept will retain the rights in the rest of the world. GNI’s wholly owned subsidiary, Shanghai Genomics, will start preparation for pre-IND and clinical development in China immediately.

17 Jul 2008

Superbug breakthrough

The week the government's chief medical officer for England, Sir Liam Donaldson, has announced that the NHS aims to create immunisation against two of the most common superbugs, MRSA and Clostridium difficile, within the next decade. But a research team led by University of Sunderland scientists has made a major breakthrough in the fight against a deadly hospital infection which kills tens of thousands of people every year, and it will be available within the next year.

17 Jul 2008

Worldwide analysis of cancer survival finds wide variation between countries

Black men and women have substantially lower survival than white men and women in the United States, but US has the highest survival for prostate cancer of all 31 countries included.

16 Jul 2008

Turning on hormone tap could aid osteoporosis fight

A potential new drug that 'opens the taps' for the release of useful hormones could stimulate new bone growth - and may eventually bring relief to osteoporosis sufferers.

From The University of Manchester 16 Jul 2008

Removal of ovaries during hysterectomy

During hysterectomy operations, surgeons often remove a woman's ovaries as well as her uterus. Cochrane Researchers now say there is no evidence that removing the ovaries provides any additional benefit and warn surgeons to consider the procedure carefully.

16 Jul 2008

Obesity 'hikes up' pancreatic cancer risk in women

Obese women, who carry most of their excess weight around the stomach, are 70 per cent more likely to develop pancreatic cancer, according to a study published online in the British Journal of Cancer.

16 Jul 2008